LinkedIn Profile

Access Hanmi Pharmaceuticals historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
krx:128940 1388950 Apr 21st, 2024 12:00AM Hanmi Pharmaceuticals 5.8K 503.00 Open Apr 21st, 2024 09:36AM Apr 21st, 2024 09:36AM Hanmi Pharmaceutical, Co., Ltd., headquartered in Seoul, South Korea, and established in 1973, has become one of the largest companies not only in Korea but also within the region, selling over 200 products worldwide. Today, Hanmi is also recognized as the No.1 R&D investing company in Korea, spending over 10~15% of the company’s annual revenue in developing next generation Platform Technologies & NCE products. For further information about Hanmi Pharmaceutical, please visit our website at www.hanmipharm.com. Open Development of NCE Pipeline - Oncology/Autoimmune/Metabolic, Development of NME Pipeline based on Long-Acting Technology(LAPSCOVERY), Development of Value-added Products, Development of FDC(Fixed Dose Combination) Products, and Sales& Marketing in Korea/China Open Hanmi Tower, 45, Bangi-dong, Songpa-gu Seoul KR 138-724 Hanmi Pharmaceuticals
krx:128940 1388950 Apr 20th, 2024 12:00AM Hanmi Pharmaceuticals 5.8K 503.00 Open Apr 20th, 2024 08:34AM Apr 21st, 2024 03:52AM Hanmi Pharmaceutical, Co., Ltd., headquartered in Seoul, South Korea, and established in 1973, has become one of the largest companies not only in Korea but also within the region, selling over 200 products worldwide. Today, Hanmi is also recognized as the No.1 R&D investing company in Korea, spending over 10~15% of the company’s annual revenue in developing next generation Platform Technologies & NCE products. For further information about Hanmi Pharmaceutical, please visit our website at www.hanmipharm.com. Open Development of NCE Pipeline - Oncology/Autoimmune/Metabolic, Development of NME Pipeline based on Long-Acting Technology(LAPSCOVERY), Development of Value-added Products, Development of FDC(Fixed Dose Combination) Products, and Sales& Marketing in Korea/China Open Hanmi Tower, 45, Bangi-dong, Songpa-gu Seoul KR 138-724 Hanmi Pharmaceuticals
krx:128940 1388950 Apr 19th, 2024 12:00AM Hanmi Pharmaceuticals 5.8K 502.00 Open Apr 19th, 2024 11:10AM Apr 19th, 2024 11:10AM Hanmi Pharmaceutical, Co., Ltd., headquartered in Seoul, South Korea, and established in 1973, has become one of the largest companies not only in Korea but also within the region, selling over 200 products worldwide. Today, Hanmi is also recognized as the No.1 R&D investing company in Korea, spending over 10~15% of the company’s annual revenue in developing next generation Platform Technologies & NCE products. For further information about Hanmi Pharmaceutical, please visit our website at www.hanmipharm.com. Open Development of NCE Pipeline - Oncology/Autoimmune/Metabolic, Development of NME Pipeline based on Long-Acting Technology(LAPSCOVERY), Development of Value-added Products, Development of FDC(Fixed Dose Combination) Products, and Sales& Marketing in Korea/China Open Hanmi Tower, 45, Bangi-dong, Songpa-gu Seoul KR 138-724 Hanmi Pharmaceuticals
krx:128940 1388950 Apr 18th, 2024 12:00AM Hanmi Pharmaceuticals 5.8K 502.00 Open Apr 18th, 2024 09:46AM Apr 19th, 2024 07:34AM Hanmi Pharmaceutical, Co., Ltd., headquartered in Seoul, South Korea, and established in 1973, has become one of the largest companies not only in Korea but also within the region, selling over 200 products worldwide. Today, Hanmi is also recognized as the No.1 R&D investing company in Korea, spending over 10~15% of the company’s annual revenue in developing next generation Platform Technologies & NCE products. For further information about Hanmi Pharmaceutical, please visit our website at www.hanmipharm.com. Open Development of NCE Pipeline - Oncology/Autoimmune/Metabolic, Development of NME Pipeline based on Long-Acting Technology(LAPSCOVERY), Development of Value-added Products, Development of FDC(Fixed Dose Combination) Products, and Sales& Marketing in Korea/China Open Hanmi Tower, 45, Bangi-dong, Songpa-gu Seoul KR 138-724 Hanmi Pharmaceuticals
krx:128940 1388950 Apr 17th, 2024 12:00AM Hanmi Pharmaceuticals 5.8K 502.00 Open Apr 17th, 2024 11:09AM Apr 17th, 2024 09:49PM Hanmi Pharmaceutical, Co., Ltd., headquartered in Seoul, South Korea, and established in 1973, has become one of the largest companies not only in Korea but also within the region, selling over 200 products worldwide. Today, Hanmi is also recognized as the No.1 R&D investing company in Korea, spending over 10~15% of the company’s annual revenue in developing next generation Platform Technologies & NCE products. For further information about Hanmi Pharmaceutical, please visit our website at www.hanmipharm.com. Open Development of NCE Pipeline - Oncology/Autoimmune/Metabolic, Development of NME Pipeline based on Long-Acting Technology(LAPSCOVERY), Development of Value-added Products, Development of FDC(Fixed Dose Combination) Products, and Sales& Marketing in Korea/China Open Hanmi Tower, 45, Bangi-dong, Songpa-gu Seoul KR 138-724 Hanmi Pharmaceuticals
krx:128940 1388950 Apr 16th, 2024 12:00AM Hanmi Pharmaceuticals 5.8K 500.00 Open Apr 16th, 2024 08:46AM Apr 16th, 2024 06:06PM Hanmi Pharmaceutical, Co., Ltd., headquartered in Seoul, South Korea, and established in 1973, has become one of the largest companies not only in Korea but also within the region, selling over 200 products worldwide. Today, Hanmi is also recognized as the No.1 R&D investing company in Korea, spending over 10~15% of the company’s annual revenue in developing next generation Platform Technologies & NCE products. For further information about Hanmi Pharmaceutical, please visit our website at www.hanmipharm.com. Open Development of NCE Pipeline - Oncology/Autoimmune/Metabolic, Development of NME Pipeline based on Long-Acting Technology(LAPSCOVERY), Development of Value-added Products, Development of FDC(Fixed Dose Combination) Products, and Sales& Marketing in Korea/China Open Hanmi Tower, 45, Bangi-dong, Songpa-gu Seoul KR 138-724 Hanmi Pharmaceuticals
krx:128940 1388950 Apr 15th, 2024 12:00AM Hanmi Pharmaceuticals 5.8K 500.00 Open Apr 15th, 2024 11:29AM Apr 16th, 2024 05:36AM Hanmi Pharmaceutical, Co., Ltd., headquartered in Seoul, South Korea, and established in 1973, has become one of the largest companies not only in Korea but also within the region, selling over 200 products worldwide. Today, Hanmi is also recognized as the No.1 R&D investing company in Korea, spending over 10~15% of the company’s annual revenue in developing next generation Platform Technologies & NCE products. For further information about Hanmi Pharmaceutical, please visit our website at www.hanmipharm.com. Open Development of NCE Pipeline - Oncology/Autoimmune/Metabolic, Development of NME Pipeline based on Long-Acting Technology(LAPSCOVERY), Development of Value-added Products, Development of FDC(Fixed Dose Combination) Products, and Sales& Marketing in Korea/China Open Hanmi Tower, 45, Bangi-dong, Songpa-gu Seoul KR 138-724 Hanmi Pharmaceuticals
krx:128940 1388950 Apr 14th, 2024 12:00AM Hanmi Pharmaceuticals 5.8K 500.00 Open Apr 14th, 2024 07:29AM Apr 14th, 2024 07:29AM Hanmi Pharmaceutical, Co., Ltd., headquartered in Seoul, South Korea, and established in 1973, has become one of the largest companies not only in Korea but also within the region, selling over 200 products worldwide. Today, Hanmi is also recognized as the No.1 R&D investing company in Korea, spending over 10~15% of the company’s annual revenue in developing next generation Platform Technologies & NCE products. For further information about Hanmi Pharmaceutical, please visit our website at www.hanmipharm.com. Open Development of NCE Pipeline - Oncology/Autoimmune/Metabolic, Development of NME Pipeline based on Long-Acting Technology(LAPSCOVERY), Development of Value-added Products, Development of FDC(Fixed Dose Combination) Products, and Sales& Marketing in Korea/China Open Hanmi Tower, 45, Bangi-dong, Songpa-gu Seoul KR 138-724 Hanmi Pharmaceuticals
krx:128940 1388950 Apr 13th, 2024 12:00AM Hanmi Pharmaceuticals 5.8K 500.00 Open Apr 13th, 2024 06:22AM Apr 13th, 2024 06:22PM Hanmi Pharmaceutical, Co., Ltd., headquartered in Seoul, South Korea, and established in 1973, has become one of the largest companies not only in Korea but also within the region, selling over 200 products worldwide. Today, Hanmi is also recognized as the No.1 R&D investing company in Korea, spending over 10~15% of the company’s annual revenue in developing next generation Platform Technologies & NCE products. For further information about Hanmi Pharmaceutical, please visit our website at www.hanmipharm.com. Open Development of NCE Pipeline - Oncology/Autoimmune/Metabolic, Development of NME Pipeline based on Long-Acting Technology(LAPSCOVERY), Development of Value-added Products, Development of FDC(Fixed Dose Combination) Products, and Sales& Marketing in Korea/China Open Hanmi Tower, 45, Bangi-dong, Songpa-gu Seoul KR 138-724 Hanmi Pharmaceuticals
krx:128940 1388950 Apr 12th, 2024 12:00AM Hanmi Pharmaceuticals 5.8K 499.00 Open Apr 12th, 2024 06:37AM Apr 12th, 2024 03:34PM Hanmi Pharmaceutical, Co., Ltd., headquartered in Seoul, South Korea, and established in 1973, has become one of the largest companies not only in Korea but also within the region, selling over 200 products worldwide. Today, Hanmi is also recognized as the No.1 R&D investing company in Korea, spending over 10~15% of the company’s annual revenue in developing next generation Platform Technologies & NCE products. For further information about Hanmi Pharmaceutical, please visit our website at www.hanmipharm.com. Open Development of NCE Pipeline - Oncology/Autoimmune/Metabolic, Development of NME Pipeline based on Long-Acting Technology(LAPSCOVERY), Development of Value-added Products, Development of FDC(Fixed Dose Combination) Products, and Sales& Marketing in Korea/China Open Hanmi Tower, 45, Bangi-dong, Songpa-gu Seoul KR 138-724 Hanmi Pharmaceuticals

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.